Bilastine 0.6% preservative-free eye drops, an effective once-daily treatment to reduce signs and symptoms of allergic conjunctivitis: A pooled analysis of two randomized clinical trials.

Gomes, P J; Ciolino, J B; Arranz, P; Gonzalo, A; Fernández, N; Hernández, G

Gomes, P J; Ciolino, J B; Arranz, P; Gonzalo, A; Fernández, N; Hernández, G.

Afiliación

Gomes PJ; Ora, Inc., Andover, MA, USA.
Ciolino JB; Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Arranz P; Research, Development and Innovation Department, FAES Farma, Bizkaia, Spain.
Gonzalo A; Research, Development and Innovation Department, FAES Farma, Bizkaia, Spain.
Fernández N; Research, Development and Innovation Department, FAES Farma, Bizkaia, Spain.
Hernández G; Research, Development and Innovation Department, FAES Farma, Bizkaia, Spain.

J Investig Allergol Clin Immunol ; : 0, 2023 Sep 21.

Article en En | MEDLINE | ID: mdl-37732873

Palabras clave

Allergic conjunctivitis; Antihistamine; Bilastine; Once-daily; Preservative-free

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies Aspecto: Patient_preference Idioma: En Revista: J Investig Allergol Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: España

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google